[artículo] 
inJournal of Clinical Psychopharmacology > Año 2011 - Vol. 31 - No. 1 (Febrero) . - pp. 4-9

Título :	High correlation between serum and cerebrospinal fluid olanzapine concentrations in patients with schizophrenia or schizoaffective disorder medicating with oral olanzapine as the only antipsychotic drug
Tipo de documento:	texto impreso
Autores:	Elisabeth Skogh, Autor ; Ingemar Sjödin, Autor ; Martin Josefsson, Autor
Fecha de publicación:	2022
Artículo en la página:	pp. 4-9
Idioma :	Inglés (eng) Idioma original : Inglés (eng)
Palabras clave:	Olanzapina, Tabaquismo, Concentración sérica, Líquido cefalorraquídeo, Farmacogenética
Resumen:	The primary aim of the present study was to investigate the relationship between steady state serum and cerebrospinal fluid (CSF) concentrations of olanzapine (OLA) and its metabolite 4′-N-desmethylolanzapine (DMO) in patients with schizophrenia or schizoaffective disorder treated with oral OLA as the only antipsychotic drug.
Link:	./index.php?lvl=notice_display&id=29401

[artículo] High correlation between serum and cerebrospinal fluid olanzapine concentrations in patients with schizophrenia or schizoaffective disorder medicating with oral olanzapine as the only antipsychotic drug [texto impreso] / Elisabeth Skogh, Autor ; Ingemar Sjödin, Autor ; Martin Josefsson, Autor . - 2022 . - pp. 4-9.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in Journal of Clinical Psychopharmacology > Año 2011 - Vol. 31 - No. 1 (Febrero) . - pp. 4-9

Palabras clave:	Olanzapina, Tabaquismo, Concentración sérica, Líquido cefalorraquídeo, Farmacogenética
Resumen:	The primary aim of the present study was to investigate the relationship between steady state serum and cerebrospinal fluid (CSF) concentrations of olanzapine (OLA) and its metabolite 4′-N-desmethylolanzapine (DMO) in patients with schizophrenia or schizoaffective disorder treated with oral OLA as the only antipsychotic drug.
Link:	./index.php?lvl=notice_display&id=29401